...
首页> 外文期刊>Journal of herbal pharmacotherapy >Clinical validation of efficacy and safety of herbal cough formula: study of herbal cough syrup.
【24h】

Clinical validation of efficacy and safety of herbal cough formula: study of herbal cough syrup.

机译:草药止咳配方的有效性和安全性的临床验证:草药止咳糖浆的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE OF THE STUDY: To clinically validate the efficacy and safety of herbal cough formula CORSHE-E of ayurvedic origin. PROCEDURE: An open label, uncontrolled clinical study was done on thirty patients with history of cough. The patients were given the cough syrup after they were enrolled in the study and were followed up for a period of seven days. The cough severity, frequency (as recorded on Visual Analogue Scale from 0 to 10 cm), chest discomfort, quantity and type of sputum were recorded at screening, on the fourth day and on the seventh day of treatment. The patient recorded the severity and frequency of cough on a Visual Analogue Scale which was divided into ten equal parts of 1 cm each. The patient marked the extent of symptoms on this scale at screening and after four days of consumption of the cough syrup. The scores were marked on these days and reduction in score was examined for efficacy evaluation of the cough syrup. The clinical and hematological safety parameters and parameters for acceptability of cough syrup (palatability, color, odor and consistency) were also studied. Global assessment by the patient and the physician was also carried out on the fourth day. RESULTS: Twenty-six of the thirty patients studied showed a significant decrease in the frequency and severity of cough (on Visual Analogue Scale). The sputum quantity and consistency also showed steady decrease and liquefaction respectively. Four patients who had longer duration of did not respond adequately to treatment. These patients had history of sub-acute to chronic cough with mean duration of cough being forty days (40 +/- 34 days), sore-throat and fever, highly suggestive of bacterial upper respiratory tract infection and a long duration of cough before initiation of therapy. Most of the patients found the cough syrup to be acceptable in terms of these criteria. Nineteen patients rated the cough syrup as excellent in palatability, two in color, four in odor and five in consistency. Six patients rated the syrup as good to taste, twenty-eight patients rated the natural color as good and twenty five and twenty patients rated the odor and consistency as good, respectively. Five patients described the taste as bad, none described the color as bad, one patient found the odor bad and five described the consistency as bad. All patients described a soothing effect of the study drug and appreciated the natural color and flavor of the same. Global assessment was based on improvement in symptoms, acceptability and overall efficacy and safety as reported by the physician and the patient. Thirteen of the thirty patients rated the trial medicine as excellent, thirteen rated it as good and four considered it poor. The investigator in charge of the patients rated the trial medicine as excellent in eighteen cases, good in eight cases, fair in two cases and poor in two cases. CONCLUSION: The test drug CORSHE-E is an effective and safe cough syrup that is highly acceptable for patients with cough of short duration.
机译:这项研究的目的:为了临床验证印度药草来源的草药咳嗽配方CORSHE-E的疗效和安全性。程序:对30名有咳嗽史的患者进行了开放标签,未经控制的临床研究。患者入选本研究后,给予其止咳糖浆,并进行为期7天的随访。在筛选,治疗的第四天和第七天记录咳嗽的严重程度,频率(按照视觉模拟量表从0到10厘米记录),胸部不适,痰的数量和类型。患者用视觉模拟量表记录咳嗽的严重程度和频率,将其分为10个相等的部分,每个部分1厘米。患者在筛查时和食用止咳糖浆四天后以这种规模标记症状的程度。在这些天标记分数,并检查分数降低以评估咳嗽糖浆的功效。还研究了临床和血液学安全性参数以及咳嗽糖浆可接受性的参数(适口性,颜色,气味和稠度)。患者和医生的全球评估也在第四天进行。结果:在研究的30例患者中,有26例显示咳嗽的频率和严重程度明显降低(根据视觉模拟量表)。痰液量和稠度也分别显示稳定下降和液化。持续时间较长的四名患者对治疗没有足够的反应。这些患者具有亚急性至慢性咳嗽的病史,平均咳嗽时间为四十天(40 +/- 34天),嗓子疼和发烧,强烈提示细菌性上呼吸道感染,并且开始前咳嗽时间长治疗。就这些标准而言,大多数患者发现咳嗽糖浆是可以接受的。 19名患者将咳嗽糖浆的可口性评为极佳,颜色为2种,气味为4种,稠度为5种。六名患者对糖浆的味道评价为良好,二十八名患者对自然色的评价为良好,二十五名和二十二名患者的气味和浓稠度为好。五位患者认为味道不好,没有人描述颜色不好,一位患者发现气味不好,五位患者称稠度不好。所有患者均描述了该研究药物的镇静作用,并欣赏了该药物的天然颜色和风味。总体评估是基于医师和患者报告的症状,可接受性以及总体功效和安全性的改善。在30名患者中,有13名将试验药物评为好,在13名中将其评为好,有4名认为其较差。负责患者的研究者对试验药物的评价为:优18例,良8例,一般2例,差2例。结论:测试药物CORSHE-E是一种有效且安全的咳嗽糖浆,对于持续时间短的咳嗽患者高度可接受。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号